Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma

被引:0
|
作者
Tao, Haisu [1 ,2 ]
Zhang, Yuxin [1 ,2 ]
Yuan, Tong [1 ,2 ]
Li, Jiang [1 ,2 ]
Liu, Junjie [1 ,2 ]
Xiong, Yixiao [1 ,2 ]
Zhu, Jinghan [1 ,2 ]
Huang, Zhiyong [1 ,2 ]
Wang, Ping [3 ]
Liang, Huifang [1 ,2 ]
Zhang, Erlei [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan, Peoples R China
[2] Hubei Key Lab Hepatopancreato Biliary Dis, Wuhan, Peoples R China
[3] Guangzhou Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Guangzhou, Peoples R China
来源
AGING-US | 2022年 / 14卷 / 03期
基金
中国国家自然科学基金;
关键词
HCC; EMT; prognostic signature; LINC01116; immune; MESENCHYMAL TRANSITION; METASTASIS; EZH2;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Epithelial-mesenchymal transition (EMT) plays a critical role in the recurrence and metastasis of hepatocellular carcinoma (HCC). Some long noncoding (lnc)RNAs are involved in this process through the regulation of EMT-related transcription factors. Methods: In this study, we established a novel EMT-related lncRNA signature in HCC and identified hub lncRNAs that can serve as potential therapeutic targets. Differentially expressed lncRNAs were identified by screening HCC patient data from The Cancer Genome Atlas, and a correlation analysis was performed to identify those associated with EMT. The EMT-related lncRNA signature was established by univariate, least absolute shrinkage and selection operator, and multivariate Cox regression analyses. After verifying the prognostic accuracy of the signature, its relationships to immune cell infiltration and immune checkpoint targets were explored. LINC01116 was identified as a hub lncRNA and its role in HCC was investigated in vitro and in vivo. YResults: A 5-lncRNA signature was developed for HCC and its prognostic accuracy was assessed by survival, time-dependent receiver operating characteristic curve, clinical correlation, and Cox regression analyses. The correlation analysis showed that the lncRNA signature was closely related to immune cell infiltration and 10 immune checkpoint targets and also predicted the prognosis of HCC patients with high accuracy. In vitro and in vivo experiments revealed that LINC01116 stimulated cell proliferation, cell cycle progression, and tumor metastasis. We also found that LINC01116 was closely related to immune regulation. Conclusions: These results demonstrate that LINC01116 is an immune-related oncogene that is associated with both EMT and immune regulation in HCC. Moreover, the EMT-related lncRNA signature that includes LINC01116 can guide risk stratification and clinical decision-making in HCC management.
引用
收藏
页码:1473 / 1491
页数:19
相关论文
共 50 条
  • [31] Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
    Bai, Yang
    Lin, Haiping
    Chen, Jiaqi
    Wu, Yulian
    Yu, Shi'an
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [32] Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
    Huang, Anmin
    Li, Ting
    Xie, Xueting
    Xia, Jinglin
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [33] Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma
    Li, Yue
    He, Xiaoqin
    Zhang, Xiaoyu
    Xu, Yangtao
    Wu, Yaogui
    Xu, Ximing
    LIFE SCIENCES, 2021, 265
  • [34] Construction of an EMT-related lncRNA prognostic signature for lung adenocarcinoma and functional verification of its hub gene LINC01615
    Yifan Shan
    Tingting Xia
    Weijia Xie
    Weiping Wan
    Na Wu
    Zhiquan Yuan
    Qin Hu
    Zheng Chen
    Chengying Li
    Long Wu
    Wenhui Wu
    Tongjian Cai
    Ying Xiang
    Li Bai
    Yafei Li
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 17781 - 17793
  • [35] A novel immune-related gene signature predicts the prognosis of hepatocellular carcinoma
    He, Shujiao
    Qiao, Jingqiao
    Wang, Lei
    Yu, Li
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [36] Development and validation of a robust immune-related risk signature for hepatocellular carcinoma
    Liu, Zaoqu
    Jiao, Dechao
    Liu, Long
    Zhou, Xueliang
    Yao, Yuan
    Li, Zhaonan
    Li, Jing
    Chen, Jianjian
    Lei, Qinyu
    Han, Xinwei
    MEDICINE, 2021, 100 (10) : E24683
  • [37] Signature of immune-related metabolic genes predicts the prognosis of hepatocellular carcinoma
    Zhuo, Weibin
    Xia, Hongmei
    Lan, Bin
    Chen, Yu
    Wang, Xuefeng
    Liu, Jingfeng
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [38] Construction of an EMT-related lncRNA prognostic signature for lung adenocarcinoma and functional verification of its hub gene LINC01615
    Shan, Yifan
    Xia, Tingting
    Xie, Weijia
    Wan, Weiping
    Wu, Na
    Yuan, Zhiquan
    Hu, Qin
    Chen, Zheng
    Li, Chengying
    Wu, Long
    Wu, Wenhui
    Cai, Tongjian
    Xiang, Ying
    Bai, Li
    Li, Yafei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (20) : 17781 - 17793
  • [39] Identification of an EMT-related gene-based prognostic signature in osteosarcoma
    Gong, Haoli
    Tao, Ye
    Xiao, Sheng
    Li, Xin
    Fang, Ke
    Wen, Jie
    Zeng, Ming
    Liu, Yiheng
    Chen, Yang
    CANCER MEDICINE, 2023, 12 (11): : 12912 - 12928
  • [40] Development of a novel immune-related lncRNA signature as a prognostic classifier for endometrial carcinoma
    Liu, Jinhui
    Mei, Jie
    Wang, Yichun
    Chen, Xucheng
    Pan, Jiadong
    Tong, Laigen
    Zhang, Yan
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (02): : 448 - 459